Literature DB >> 29876610

[Possibilities and limitations of molecular pathology in dermatohistology].

V Schacht1, U Lehmann2, T Reineke-Plaass2, F Länger2, B Auber3, S Morlot3, H-H Kreipe2.   

Abstract

Malignant tumours, infections caused by microorganisms or genodermatoses are diagnosed with additional help of molecular pathology methods. Polymerase chain reaction (PCR), sequencing and in situ hybridisations play an important role. It remains to be seen if methods such as "liquid biopsies" or "single cell genomics" can be developed as routine diagnostics. High technical efforts, high costs and no possibility for resistency testing is accompanied by fast verification, high sensitivity and high specificity. Overall, molecular pathology results have to be combined with the clinical picture, histology or immunohistochemistry and culturing results to achieve a correct diagnosis for the patient.

Entities:  

Keywords:  Fluorescence in situ hybridization; Monoclonal expansion; Mutation; Polymerase chain reaction; Sequencing

Mesh:

Substances:

Year:  2018        PMID: 29876610     DOI: 10.1007/s00105-018-4206-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  24 in total

Review 1.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

Review 2.  Molecular diagnostics in infectious skin diseases.

Authors:  Werner Kempf; Michael J Flaig; Heinz Kutzner
Journal:  J Dtsch Dermatol Ges       Date:  2013-05       Impact factor: 5.584

3.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

Review 4.  Cutaneous angiosarcoma: a current update.

Authors:  Elina Shustef; Viktoryia Kazlouskaya; Victor G Prieto; Doina Ivan; Phyu P Aung
Journal:  J Clin Pathol       Date:  2017-09-15       Impact factor: 3.411

5.  Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.

Authors:  Klaus G Griewank; Thomas Wiesner; Rajmohan Murali; Carina Pischler; Hansgeorg Müller; Christian Koelsche; Inga Möller; Cindy Franklin; Ioana Cosgarea; Antje Sucker; Dirk Schadendorf; Jörg Schaller; Susanne Horn; Thomas Brenn; Thomas Mentzel
Journal:  Mod Pathol       Date:  2017-11-03       Impact factor: 7.842

Review 6.  Molecular and Genomic Determinants of Response to Immune Checkpoint Inhibition in Cancer.

Authors:  Russell W Jenkins; Rohit Thummalapalli; Jacob Carter; Israel Cañadas; David A Barbie
Journal:  Annu Rev Med       Date:  2017-11-03       Impact factor: 13.739

Review 7.  Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.

Authors:  Khin Thway; Jonathan Noujaim; Robin L Jones; Cyril Fisher
Journal:  Ann Diagn Pathol       Date:  2016-09-27       Impact factor: 2.090

8.  Immunohistochemistry and polymerase chain reaction on paraffin-embedded material improve the diagnosis of cutaneous leishmaniasis in the Amazon region.

Authors:  Valdir Sabbaga Amato; Felipe Francisco Tuon; Heitor Franco de Andrade; Helio Bacha; Carla Pagliari; Elaine Raniero Fernandes; Maria Irma Seixas Duarte; Vicente Amato Neto; Ricardo Andrade Zampieri; Lucile Maria Floeter-Winter; Beatriz J Celeste; Juliane Oliveira; Mariana Martinez Quiroga; Melissa Mascheretti; Marcos Boulos
Journal:  Int J Dermatol       Date:  2009-10       Impact factor: 2.736

9.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

10.  The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.

Authors:  Jonathan Noujaim; Robin L Jones; John Swansbury; David Gonzalez; Charlotte Benson; Ian Judson; Cyril Fisher; Khin Thway
Journal:  Br J Cancer       Date:  2017-01-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.